News
Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...
Meta is rolling out Reels trending ads, value rules beyond just conversions, upgrades to Threads and pixel-free landing page ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback